新药-话题@MedSci

#新药#

5篇内容 | 2677人围观

关注话题

话题活跃用户

#插入话题

插入图片

最新最热

[GetTopicListResponse(id=2247435, encodeId=6405224e43514, content=<a href='/topic/show?id=942b4516096' target=_blank style='color:#2F92EE;'>#子宫内膜癌#</a><a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a>临床研发, objectTitle=治疗子宫内膜癌新药临床研发技术指导原则（试行）, objectType=guider, longId=33987, objectId=87ce41c00a1348dc, topicUrl=null, isHasObj=0, objectCover=null, objectUrl=/guideline/show_article.do?id=87ce41c00a1348dc, replyNumber=0, likeNumber=21, createdTime=2025-01-10, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=87ce41c00a1348dc, moduleTitle=治疗子宫内膜癌新药临床研发技术指导原则（试行）, moduleType=guider, hrefUrl=https://www.medsci.cn/guideline/show_article.do?id=87ce41c00a1348dc)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2212250, encodeId=c4be221225026, content=<a href='/topic/show?id=cf292341925' target=_blank style='color:#2F92EE;'>#乙肝#</a> <a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a>, objectTitle=【会议撷萃】庄辉院士：关于乙肝新药临床试验的几点思考, objectType=article, longId=828545, objectId=d61c828545ec, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20240622/1719052477412_5579292.png, objectUrl=/article/show_article.do?id=d61c828545ec, replyNumber=0, likeNumber=101, createdTime=2024-06-28, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=d61c828545ec, moduleTitle=【会议撷萃】庄辉院士：关于乙肝新药临床试验的几点思考, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=d61c828545ec)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2176842, encodeId=2df221e684200, content=<a href='/topic/show?id=aa0582e6946' target=_blank style='color:#2F92EE;'>#肿瘤#</a> <a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a> <a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a> <a href='/topic/show?id=3ecb5564852' target=_blank style='color:#2F92EE;'>#抗肿瘤新药#</a>, objectTitle=一图汇总！2023年FDA批准的抗肿瘤新药及适应症, objectType=article, longId=806617, objectId=c3ff80661eae, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20231222/c902650219fa415ca1d30f061bce7b44.jpg, objectUrl=/article/show_article.do?id=c3ff80661eae, replyNumber=0, likeNumber=169, createdTime=2023-12-24, rootId=0, userName=梅斯管理员, userId=cade5395722, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=威斯康星, moduleDTOList=[ModuleDTO(moduleId=c3ff80661eae, moduleTitle=一图汇总！2023年FDA批准的抗肿瘤新药及适应症, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=c3ff80661eae)], followStatus=false, userIsMember=false, type=null, lengthMark=0), GetTopicListResponse(id=2130450, encodeId=585d213045012, content=<a href='/topic/show?id=9b41614554a' target=_blank style='color:#2F92EE;'>#李进#</a>教授：<a href='/topic/show?id=de4d9343316' target=_blank style='color:#2F92EE;'>#转移性胃癌#</a><a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a>进展, objectTitle=CSCO 2023 | 李进教授：转移性胃癌新药进展及指南更新要点, objectType=article, longId=768269, objectId=6b4be68269b6, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/images/20230411/5a2024f42a9e47b9b7ad9d60525d82f5.jpg, objectUrl=/article/show_article.do?id=6b4be68269b6, replyNumber=0, likeNumber=144, createdTime=2023-05-06, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=6b4be68269b6, moduleTitle=CSCO 2023 | 李进教授：转移性胃癌新药进展及指南更新要点, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=6b4be68269b6)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=2123634, encodeId=e58b212363452, content=<a href='/topic/show?id=f336e29134' target=_blank style='color:#2F92EE;'>#FDA#</a>批准<a href='/topic/show?id=987b103432fe' target=_blank style='color:#2F92EE;'>#鼻喷雾剂#</a><a href='/topic/show?id=a6c1105e74ed' target=_blank style='color:#2F92EE;'>#Zavegepant#</a>上市，15分钟缓解<a href='/topic/show?id=1ffc2e613ae' target=_blank style='color:#2F92EE;'>#偏头痛#</a>，<a href='/topic/show?id=0422105e751f' target=_blank style='color:#2F92EE;'>#偏头痛网#</a><a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a>, objectTitle=FDA批准鼻喷雾剂Zavegepant上市，15分钟缓解偏头痛, objectType=article, longId=762497, objectId=1db1e62497d5, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20230312/1678654136367_4754896.jpeg, objectUrl=/article/show_article.do?id=1db1e62497d5, replyNumber=0, likeNumber=149, createdTime=2023-04-04, rootId=0, userName=侠胆医心, userId=f63e4754896, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=上海, moduleDTOList=[ModuleDTO(moduleId=1db1e62497d5, moduleTitle=FDA批准鼻喷雾剂Zavegepant上市，15分钟缓解偏头痛, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=1db1e62497d5)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=1222002, encodeId=cb7312220029a, content=<a href='/topic/show?id=08f236865a8' target=_blank style='color:#2F92EE;'>#卵巢癌#</a><a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a><a href='/topic/show?id=e08113e613e' target=_blank style='color:#2F92EE;'>#PARP抑制剂#</a>纳入<a href='/topic/show?id=e85c33804e5' target=_blank style='color:#2F92EE;'>#医保#</a>, objectTitle=卵巢癌新药纳入医保专家：患者月均自付费用低至两三千元, objectType=article, longId=208021, objectId=3d01208021e0, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/202137/1615048421614_2119349.jpg, objectUrl=/article/show_article.do?id=3d01208021e0, replyNumber=0, likeNumber=211, createdTime=2022-05-24, rootId=0, userName=清风徐来2022, userId=7a3710, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=3d01208021e0, moduleTitle=卵巢癌新药纳入医保专家：患者月均自付费用低至两三千元, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=3d01208021e0)], followStatus=false, userIsMember=false, type=1, lengthMark=0), GetTopicListResponse(id=908101, encodeId=e5b99081016b, content=新药上市获批，使得更多的患者获益，利好的消息。<a href='/topic/show?id=d3c65861e2f' target=_blank style='color:#2F92EE;'>#新药#</a> , objectTitle=2021年，这14款重磅新药将在中国获批, objectType=article, longId=204511, objectId=652f204511c4, topicUrl=null, isHasObj=0, objectCover=https://img.medsci.cn/20201214/1607935089938_5295905.jpg, objectUrl=/article/show_article.do?id=652f204511c4, replyNumber=0, likeNumber=227, createdTime=2020-12-15, rootId=0, userName=Jessie Zhang, userId=c7015311102, projectId=1, avatar=, status=1, hasArticle=1, attachment=null, ipAttribution=, moduleDTOList=[ModuleDTO(moduleId=652f204511c4, moduleTitle=2021年，这14款重磅新药将在中国获批, moduleType=article, hrefUrl=https://www.medsci.cn/article/show_article.do?id=652f204511c4)], followStatus=false, userIsMember=false, type=1, lengthMark=0)] 梅斯话题小助手

新药

2020-05-29

侠胆医心

#子宫内膜癌##新药#临床研发

治疗子宫内膜癌新药临床研发技术指导原则（试行）

2025-01-10发表于威斯康星

梅斯管理员

#乙肝# #新药#

【会议撷萃】庄辉院士：关于乙肝新药临床试验的几点思考

2024-06-28发表于上海

梅斯管理员

#肿瘤# #FDA# #新药# #抗肿瘤新药#

一图汇总！2023年FDA批准的抗肿瘤新药及适应症

2023-12-24发表于威斯康星

侠胆医心

#李进#教授：#转移性胃癌##新药#进展

CSCO 2023 | 李进教授：转移性胃癌新药进展及指南更新要点

2023-05-06发表于上海

侠胆医心

#FDA#批准#鼻喷雾剂##Zavegepant#上市，15分钟缓解#偏头痛#，#偏头痛网##新药#

FDA批准鼻喷雾剂Zavegepant上市，15分钟缓解偏头痛

2023-04-04发表于上海

清风徐来2022

#卵巢癌##新药##PARP抑制剂#纳入#医保#

卵巢癌新药纳入医保专家：患者月均自付费用低至两三千元

2022-05-24

Jessie Zhang

新药上市获批，使得更多的患者获益，利好的消息。#新药#

2021年，这14款重磅新药将在中国获批

2020-12-15

科室
- - 订阅+
  - 更多科室
工具
服务